SQZ Biotechnologies Co Quarterly Debt-to-equity in % from Q2 2021 to Q3 2023

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: SQZ Biotechnologies Co quarterly Debt-to-equity history and growth rate from Q2 2021 to Q3 2023.
SQZ Biotechnologies Co Debt-to-equity for the quarter ending September 30, 2023 was 108 %, a 10.3% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2023	108	+10.1	+10.3%	Sep 30, 2023
Q2 2023	101	+11.6	+13%	Jun 30, 2023
Q1 2023	100	+23.4	+30.4%	Mar 31, 2023
Q4 2022	99.4	+31.7	+46.7%	Dec 31, 2022
Q3 2022	97.6	+29.9	+44.2%	Sep 30, 2022
Q2 2022	89.1	-24	-21.2%	Jun 30, 2022
Q1 2022	76.7			Mar 31, 2022
Q4 2021	67.8			Dec 31, 2021
Q3 2021	67.7			Sep 30, 2021
Q2 2021	113			Jun 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.